KOSPIChemicals161000

Aekyung Chemical

₩8,750▼ 2.02%2026-11-18 close
Market Cap
₩425.7B
Turnover
₩1.7B
Volume
190K
Shares out.
48.7M
PER
745.8×
PBR
0.6×
EPS
₩12
Dividend Yield
1.56%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩140 per share · Prices as of the 2026-11-18 close

01

Report overview

Plasticizer Losses Narrow, but Sustained Profit Is Unproven

After an operating loss in 2025, Aekyung Chemical posted operating profit in all three quarters of 2026, while net income attributable to controlling shareholders was positive only in the second quarter.

  1. 1

    Sales fell from KRW 2.18 trillion in 2022 to KRW 1.45 trillion in 2025, with three straight annual declines since 2023.

  2. 2

    The operating margin slid from 4.4% in 2022 to -0.7% in 2025, when an operating loss of KRW 10.2 billion turned the year from profit to loss.

  3. 3

    Operating profit reached KRW 42.8 billion in the second quarter of 2026, then fell 93.3% quarter on quarter to KRW 2.85 billion in the third quarter.

  4. 4

    Plasticizer sales dropped from about KRW 1.01 trillion in 2022 to KRW 626.2 billion in 2025, as Chinese oversupply pressured commodity spreads.

  5. 5

    Borrowings rose from KRW 250.4 billion in 2022 to KRW 504.9 billion in 2025, and the liabilities-to-equity ratio reached 94.6% at the end of 2025.

02

Business structure

Aekyung Chemical runs four business segments: plasticizers, synthetic resins, household and specialty chemicals, and bio & energy. Based on its 2024 annual report, plasticizers accounted for 47.6% of sales, household and specialty chemicals 20.9%, bio & energy 16.1%, synthetic resins 12.8%, and other 2.6%.

The plasticizer business covers PA, plasticizers and lubricant base oils, and the company is described as the largest domestic plasticizer maker. Plasticizer segment sales declined from about KRW 1.01 trillion in 2022 to KRW 865.5 billion in 2023, KRW 781.3 billion in 2024 and KRW 626.2 billion in 2025.

Household chemicals center on surfactants and refined glycerin, while bio & energy centers on biodiesel, bio heavy oil and hard carbon. Synthetic resins cover composite materials, coating resins and PU.

At the end of 2025, exports accounted for 73.33% of PA, plasticizer and lubricant base oil sales, against 0.02% for the biodiesel line, so overseas exposure differs sharply by product.

Key customers are industrial users such as building materials, medical supplies, automotive and electric-wire makers, many of which process PVC. Commodity products such as plasticizers face price pressure from Chinese capacity additions.

The company merged Aekyung Chemical's predecessors in 2021 to build an integrated chemical platform, and it is pursuing efficiency gains alongside new businesses.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩357.8B-₩7.3B−2.1%
2025Q4₩348.4B-₩5.5B−1.6%
2026Q1₩370.6B₩5.8B1.6%
2026Q2₩503.3B₩42.8B8.5%
2026Q3₩480.6B₩2.9B0.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩2.2T₩95.1B₩60.1B4.4%8.3%69.5%
2023₩1.8T₩45.1B₩33.1B2.5%4.5%77.7%
2024₩1.6T₩15.5B₩4B0.9%0.5%83.1%
2025₩1.5T-₩10.2B-₩2.9B−0.7%−0.4%94.6%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

Annual sales fell from KRW 2.18 trillion in 2022 to KRW 1.79 trillion in 2023 (down 17.6% year on year), KRW 1.64 trillion in 2024 (down 8.4%) and KRW 1.45 trillion in 2025 (down 11.6%).

Sales declined for three consecutive years from 2023 through 2025, and 2022 was the largest year and 2025 the smallest within 2022 to 2025.

Operating profit fell from KRW 95.1 billion in 2022 to KRW 45.1 billion in 2023 (down 52.6%) and KRW 15.5 billion in 2024 (down 65.7%), then turned into an operating loss of KRW 10.2 billion in 2025. The operating margin moved from 4.4% in 2022 to 2.5% in 2023, 0.9% in 2024 and -0.7% in 2025.

Net income attributable to controlling shareholders went from KRW 60.1 billion in 2022 to KRW 33.1 billion in 2023 (down 45.0%) and KRW 3.98 billion in 2024 (down 88.0%), and became a net loss of KRW 2.95 billion in 2025.

Net income including non-controlling interests, at a net loss of KRW 4.93 billion in 2025, is a separate figure and should not be read as the controlling-shareholder result. Industry analysis points to cost of sales rising from 89.7% of sales in 2022 to above 90% in 2023 and 91.4% in 2024.

Raw material prices fell, but selling prices fell further, which compressed spreads. Quarterly, the third quarter of 2025 showed sales of KRW 357.8 billion and an operating loss of KRW 7.34 billion, and the fourth quarter sales of KRW 348.4 billion with an operating loss of KRW 5.51 billion.

The first quarter of 2026 turned to operating profit of KRW 5.82 billion on sales of KRW 370.6 billion. Second-quarter sales rose to KRW 503.3 billion (up 35.8% quarter on quarter) and operating profit to KRW 42.8 billion (up 636.6%).

Third-quarter sales of KRW 480.6 billion (down 4.5% quarter on quarter, up 34.3% year on year) stayed high, but operating profit fell to KRW 2.85 billion (down 93.3% quarter on quarter).

Net income attributable to controlling shareholders swung from KRW 14.5 billion in the third quarter of 2025 to a net loss of KRW 9.69 billion in the fourth quarter, a net loss of KRW 1.25 billion in the first quarter of 2026, a profit of KRW 16.4 billion in the second quarter and a net loss of KRW 4.84 billion in the third.

Whether second-quarter profit was one-off, and what drove the third-quarter drop, are points to confirm in the quarterly report's segment items and notes.

05

Industry analysis

The petrochemical cycle is under pressure as Chinese capacity additions and weak global demand reinforce each other. Commodity products such as plasticizers and synthetic resins have seen spreads narrow, and industry observers see no quick reversal in the domestic petrochemical cycle.

Between 2022 and 2024, many domestic chemical companies swung to losses while Aekyung Chemical stayed profitable, but it recorded its first annual loss since the merger in 2025. A 2025 report said foreign suppliers, including Chinese producers, were eroding the domestic plasticizer market.

Prosecutors indicted six petrochemical companies, including LG Chem and LOTTE Fine Chemical, along with 37 current and former executives in early October 2026, over alleged price collusion in eight products including PVC and plasticizers from January 2021 to April 2026.

The sales volume prosecutors attributed to the alleged collusion was KRW 16.40 trillion, and four Aekyung Chemical employees were also indicted. A press report noted that official plasticizer selling prices fell even during the period under suspicion.

Aekyung Chemical is a domestic plasticizer leader, but the decline in plasticizer sales has exposed the limits of relying on commodity products. Its new businesses, including TPC and hard carbon, are the company's attempt to reduce that dependence.

06

Outlook

Aekyung Chemical's new businesses fall into four areas: TPC, anode materials, hard carbon and eco-friendly plasticizers. TPC (terephthaloyl chloride) is a core raw material for aramid fiber, and the Ulsan plant has a capacity of 15,000 tons, with full-scale production reported as imminent in 2026.

Reports also suggest the company could replace TPC volumes that had depended on Chinese imports. In December 2025 the company decided to invest in a production line expansion at its Jeonju plant, aiming to build it into the first mass-production facility for sodium-ion battery anode materials.

Hard carbon is at pilot production, and the timing of commercial output will be a key variable. Eco-friendly plasticizers made from recycled PET have moved into mass production, and the company has reported ISCC PLUS and GRS certifications.

On September 30, 2026 the company filed a corrected disclosure on new facility investment, and the subsequent execution will show the scale of capital spending. Borrowings that rose from KRW 250.4 billion in 2022 to KRW 504.9 billion in 2025 may limit room for further investment funding.

The criminal trial over the alleged collusion and any administrative sanctions remain variables for future cash flow and investment capacity. The next checkpoint is segment sales and capex execution for the new businesses in the 2026 annual report.

07

Valuation

PER
745.8×
PBR
0.6×
ROE
0.1%
EPS
₩12
BPS
₩14,820
Dividend per share
₩140

Price-to-book sits below 1x, meaning the share price is low relative to book equity at the end of 2025 (KRW 716.4 billion in total equity, of which KRW 714.1 billion belongs to controlling shareholders).

However, total liabilities of KRW 677.9 billion and a liabilities-to-equity ratio that rose from 69.5% in 2022 to 94.6% in 2025 mean the quality of that book value depends on how fast profitability recovers.

Earnings-based multiples are hard to compare meaningfully because of the 2025 operating and net losses, and net income attributable to controlling shareholders has swung quarter to quarter in 2026, leaving a small earnings base over the last four quarters.

A press report said dividends continued after the 2025 loss, following a payout ratio of 159% in 2024, so cash dividends and rising borrowings have run in parallel. Whether dividends can be sustained should be read alongside the pace of earnings recovery.

From a valuation standpoint, the key question is whether earnings recovery can catch up with the balance-sheet value, and the multiple will be easier to read once full-year earnings after the fourth quarter of 2026 are confirmed.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Operating profit back in the black

Operating profit turned positive in the first quarter of 2026 at KRW 5.82 billion and rose to KRW 42.8 billion in the second quarter. Three straight quarters of positive operating profit after the 2025 loss point to partial recovery in operating capacity.

If the operating margin improves from -0.7% in 2025, there is room to widen the earnings recovery. Still, third-quarter operating profit of KRW 2.85 billion fell 93.3% from the second quarter, so quarterly volatility is large.

Expanding new-business portfolio

TPC, used in aramid fiber, is reported to be entering full-scale production in 2026 at a 15,000-ton Ulsan plant. Sodium-ion battery anode material is being built out through a production-line expansion at the Jeonju plant. Eco-friendly plasticizers from recycled PET have secured ISCC PLUS and GRS certifications. If these businesses reduce reliance on commodity products, earnings volatility could narrow over time.

Asset sales and cash build

In 2025 the company sold the Joongbu Country Club golf course for KRW 169 billion to secure cash. Cash and cash equivalents rose to KRW 190.7 billion at the end of the third quarter of 2025, from KRW 66.8 billion at the end of 2024. Over the same period, net borrowings fell from KRW 330.3 billion to KRW 289.2 billion. Asset sales have provided a liquidity buffer that eases the financial burden during the earnings slump.

09

Bear factors

Cost ratio stuck high amid oversupply

Cost of sales rose above 90% of sales in 2023 and reached 91.4% in 2024, according to industry analysis. Chinese capacity additions are squeezing plasticizer and synthetic resin spreads. Plasticizer segment sales fell from about KRW 1.01 trillion in 2022 to KRW 626.2 billion in 2025. While the cost ratio stays above 90%, the scope for the operating margin to recover may stay limited.

Rising borrowings and weaker cash flow

Borrowings rose from KRW 250.4 billion in 2022 to KRW 504.9 billion in 2025. Operating cash flow fell from KRW 137 billion in 2022 to KRW 27.9 billion in 2025. The liabilities-to-equity ratio climbed from 69.5% to 94.6% over the same span. Borrowings increasing while dividends continued could narrow financial flexibility.

Collusion indictment and unstable earnings

In early October 2026 prosecutors indicted six petrochemical companies and 37 current and former executives for alleged violations of the Fair Trade Act, including four Aekyung Chemical employees. The outcome of the criminal trial will determine the resulting financial burden.

On earnings, net income attributable to controlling shareholders swung back to a net loss of KRW 4.84 billion in the third quarter of 2026, so quarterly profit has not stabilized.

10

Risk factors

Raw material spreads and oversupply

Chinese capacity additions combined with weak global demand could keep selling prices of commodity products under pressure. When raw material prices fall but selling prices fall further, spreads narrow again. The 91.4% cost ratio in 2024 shows that this structural pressure has not eased easily.

If plasticizer sales keep declining from the KRW 626.2 billion reached in 2025, a recovery in top-line growth could be delayed.

Collusion trial and administrative sanctions

The collusion case, which covers six petrochemical companies and their executives, is proceeding through a criminal trial. Prosecutors attributed alleged collusion-related sales of KRW 16.40 trillion, indicating the scale of the case. Depending on the verdict, fines or penalties could weigh on earnings and cash flow. Financial planning will carry uncertainty until the trial concludes.

Borrowings, cash flow and dividends

Borrowings at the end of 2025 stood at KRW 504.9 billion, more than double the KRW 250.4 billion of 2022. Operating cash flow fell to KRW 27.9 billion in 2025, which makes it harder to fund debt repayment and capex from internal cash. Dividends continuing after the 2025 loss add to cash outflows. If new-business investment is executed, dependence on borrowing could rise further.

11

What to watch next

  1. After December 2026 (depends on trial schedule)

    Progress and verdict of the criminal trial over the alleged collusion. The fines or penalties and their financial impact will become clear with the ruling.

  2. After December 2026 (timing set by company announcements)

    Ramp-up of the Ulsan TPC plant and whether hard carbon moves into commercial output. Whether new-business revenue shows up in segment results is the point to confirm.

  3. End of March 2027 (annual report filing deadline)

    Fourth-quarter and full-year 2026 results, segment sales and borrowing levels in the 2026 annual report. This is when fourth-quarter 2026 results are first confirmed in a regular filing.

  4. Mid-May 2027 (quarterly report filing deadline)

    Operating margin and net income attributable to controlling shareholders in the first-quarter 2027 report. This will show whether earnings strength holds after the first-quarter 2026 turn to profit.

12

Overall view

Aekyung Chemical's sales peaked at KRW 2.18 trillion in 2022 and then declined for three straight years through 2025, while the operating margin fell from 4.4% to -0.7%, turning the year into an operating loss in 2025.

Operating profit was positive in all three quarters of 2026, but net income attributable to controlling shareholders was positive only in the second quarter at KRW 16.4 billion, and the quarter-to-quarter swings mean the durability of the recovery is still unproven.

The main drivers are Chinese capacity additions that created oversupply and a narrowing of spreads in plasticizer-led commodity products, with cost of sales stuck at 91.4% in 2024.

Bullish factors include the recovery in quarterly operating profit, investment in new businesses such as TPC, anode materials and hard carbon, and better liquidity from the Joongbu Country Club sale and higher cash balances.

Bearish factors include a balance sheet in which borrowings rose from KRW 250.4 billion in 2022 to KRW 504.9 billion in 2025 and the liabilities-to-equity ratio reached 94.6%, operating cash flow of KRW 27.9 billion in 2025, and the criminal trial over petrochemical collusion.

Dividends continued after the 2025 loss, but with a thin earnings base their sustainability depends on how fast profit recovers.

The next checkpoints are the outcome of the collusion trial, the full-year operating margin and liabilities-to-equity ratio in the 2026 annual report, and when the new-business plants reach operation.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. butler.works
  2. m.thebell.co.kr
  3. comp.wisereport.co.kr
  4. aekyungchemical.co.kr
  5. topdaily.kr
  6. alphasquare.co.kr
  7. dealsite.co.kr
  8. s-econ.kr
  9. catch.co.kr
  10. investing.com
  11. job-post.co.kr
  12. goinsider.kr
  13. comp.wisereport.co.kr
  14. news.nate.com
  15. m.ceoscoredaily.com
  16. keyzard.cc
  17. plus.hankyung.com
  18. thebell.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis